200670 — Humedix Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapHigh Flyer

Market Cap
KR₩504bn
Enterprise Value
KR₩378bn
Revenue
KR₩162bn

Annual cashflow statement for Humedix Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	17,215	10,051	21,154	24,821	39,259
Depreciation
Amortisation
Non-Cash Items	1,628	2,224	10,751	16,138	7,793
Discontinued Operations
Unusual Items
Purchased R&D
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-5,601	-13,572	-5,245	-21,351	-7,780
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	23,762	10,978	38,152	30,885	50,744
Capital Expenditures	-17,692	-14,743	-7,280	-9,030	-8,665
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-12,120	-35,611	61,236	-6,444	-3,909
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-29,812	-50,354	53,956	-15,474	-12,575
Financing Cash Flow Items	714	-7.06	—	-18,166	16.2
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	15,606	20,064	-10,624	-25,808	-9,888
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	9,559	-19,303	81,350	-10,456	30,077